Abstract
Background: Hyposmia is frequently reported as an initial symptom in coronavirus disease 2019 (COVID-19). Objective: As hyposmia accompanies cognitive impairment in several neurological disorders, we aimed to study whether hyposmia represents a clinical biomarker for both neurological involvement and cognitive impairment in mild CO-VID-19. We aimed to study whether olfactory dysfunction (OD) represents a clinical biomarker for both neurological involvement and cognitive impairment in mild COVID-19. Methods: Formal olfactory testing using the Sniffin’Sticks® Screening test, neuropsychological assessment using the Montreal Cognitive Assessment (MoCA), and detailed neurological examination were performed in 7 COVID-19 patients with mild disease course and no history of olfactory or cognitive impairment, and 7 controls matched for age, sex, and education. Controls were initially admitted to a dedicated COVID-19 screening ward but tested negative by real-time PCR. Results: The number of correctly identified odors was significantly lower in COVID-19 than in controls (6 ± 3, vs. 10 ± 1 p = 0.028, r = 0.58). Total MoCA score was significantly lower in COVID-19 patients than in controls (20 ± 5 vs. 26 ± 3, p = 0.042, r = 0.54). Cognitive performance indicated by MoCA was associated with number of correctly identified odors in COVID-19 patients and controls (COVID-19: p = 0.018, 95% CI = 9–19; controls: p = 0.18, r = 0.63, 95% CI = 13–18.5 r = 0.64). Discussion/Conclusion: OD is associated with cognitive impairment in controls and mild COVID-19. OD may represent a potentially useful clinical biomarker for subtle and even subclinical neurological involvement in severe acute respiratory distress syndrome coronavirus-2 infection.
References
1.
Moein
ST
, Hashemian
SMR
, Mansourafshar
B
, Khorram-Tousi
A
, Tabarsi
P
, Doty
RL
. Smell dysfunction: a biomarker for COVID-19
. Internat Forum Allergy Rhinol
. 2020
;10
:944
–50
.2.
Lechien
JR
, Chiesa-Estomba
CM
, De Siati
DR
, Horoi
M
, Le Bon
SD
, Rodriguez
A
, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
. Eur Arch Otorhinolaryngol
. 2020 Aug
;277
(8
):2251
–61
. .3.
Churnin
I
, Qazi
J
, Fermin
CR
, Wilson
JH
, Payne
SC
, Mattos
JL
. Association between olfactory and gustatory dysfunction and cognition in older adults
. Am J Rhinol Allergy
. 2019 Mar
;33
(2
):170
–7
. .4.
Dintica
CS
, Marseglia
A
, Rizzuto
D
, Wang
R
, Seubert
J
, Arfanakis
K
, et al. Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain
. Neurology
. 2019
;92
(7
):e700
–9
. .5.
Saini
D
, Mukherjee
A
, Roy
A
, Biswas
A
. A comparative study of the behavioral profile of the behavioral variant of frontotemporal dementia and Parkinson’s disease dementia
. Dement Geriatr Cogn Dis Extra
. 2020 Sep-Dec
;10
(3
):182
–94
. .6.
Domellof
ME
, Lundin
KF
, Edstrom
M
, Forsgren
L
. Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson’s disease
. Parkinsonism Relat Disord
. 2017 May
;38
:41
–7
.7.
Marin
C
, Vilas
D
, Langdon
C
, Alobid
I
, López-Chacón
M
, Haehner
A
, et al. Olfactory dysfunction in neurodegenerative diseases
. Curr Allergy Asthma Rep
. 2018 Jun 15
;18
(8
):42
. .8.
Shin
T
, Kim
J
, Ahn
M
, Moon
C
. Olfactory dysfunction in CNS neuroimmunological disorders: a review
. Mol Neurobiol
. 2019 May
;56
(5
):3714
–21
. .9.
Bagheri
SHR
, Asghari
AM
, Farhadi
M
, Shamshiri
AR
, Kabir
A
, Kamrava
SK
, et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak
. medRxiv
. 2020
.10.
Yan
CH
, Faraji
F
, Prajapati
DP
, Boone
CE
, DeConde
AS
. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms
. Int Forum Allergy Rhinol
. 2020
;10
(7
):806
–13
. .11.
Helms
J
, Kremer
S
, Merdji
H
, Clere-Jehl
R
, Schenck
M
, Kummerlen
C
, et al. Neurologic features in severe SARS-CoV-2 infection
. N Engl J Med
. 2020
;382
(23
):2268
–70
. .12.
Mao
L
, Jin
H
, Wang
M
, Hu
Y
, Chen
S
, He
Q
, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
. JAMA Neurol
. 2020
;77
:683
–90
.13.
Lechien
JR
, Chiesa-Estomba
CM
, Place
S
, Van Laethem
Y
, Cabaraux
P
, Mat
Q
, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019
. J Intern Med
. 2020 Sep
;288
(3
):335
–44
. .14.
Divani
AA
, Andalib
S
, Biller
J
, Di Napoli
M
, Moghimi
N
, Rubinos
CA
, et al. Central nervous system manifestations associated with COVID-19
. Curr Neurol Neurosci Rep
. 2020 October 30
;20
(12
):60
. .15.
Moriguchi
T
, Harii
N
, Goto
J
, Harada
D
, Sugawara
H
, Takamino
J
, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
. Int J Infect Dis
. 2020 Apr 3
;94
:55
–8
. .16.
Chen
T
, Wu
D
, Chen
H
, Yan
W
, Yang
D
, Chen
G
, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
. Bmj
. 2020 Mar 26
;368
:m1091
. .17.
Hadziefendic
S
, Haxhiu
MA
. CNS innervation of vagal preganglionic neurons controlling peripheral airways: a transneuronal labeling study using pseudorabies virus
. J Auton Nerv Syst
. 1999 May 28
;76
(2–3
):135
–45
. .18.
Matsuda
K
, Park
CH
, Sunden
Y
, Kimura
T
, Ochiai
K
, Kida
H
, et al. The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice
. Vet Pathol
. 2004 Mar
;41
(2
):101
–7
. .19.
Li
YC
, Bai
WZ
, Hashikawa
T
. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients
. J Med Virol
. 2020 Feb 27
;92
:55
–5
.20.
Hummel
T
, Sekinger
B
, Wolf
SR
, Pauli
E
, Kobal
G
. ‘Sniffin’ sticks’: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold
. Chem Senses
. 1997 Feb
;22
(1
):39
–52
. .21.
Tan
JP
, Li
N
, Gao
J
, Wang
LN
, Zhao
YM
, Yu
BC
, et al. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population
. J Alzheimers Dis
. 2015
;43
(4
):1403
–12
. .22.
Zhou
Y
, Ortiz
F
, Nuñez
C
, Elashoff
D
, Woo
E
, Apostolova
LG
, et al. Use of the MoCA in detecting early Alzheimer’s disease in a spanish-speaking population with varied levels of education
. Dement Geriatr Cogn Dis Extra
. 2015
;5
(1
):85
–95
. .23.
Atalar
AÇ
, Erdal
Y
, Tekin
B
, Yıldız
M
, Akdoğan
Ö
, Emre
U
. Olfactory dysfunction in multiple sclerosis
. Mult Scler Relat Disord
. 2018 Apr
;21
:92
–6
. .24.
Pirker
A
, Schmied
C
, Dal-Bianco
P
. T-cells show increased production of cytokines and activation markers in Alzheimer’s disease
. Brain Disord. Ther
. 2013
;3
(1
):4
.25.
Sochocka
M
, Zwolińska
K
, Leszek
J
. The infectious etiology of Alzheimer’s disease
. Curr Neuropharmacol
. 2017
;15
(7
):996
–1009
. .26.
Chen
N
, Zhou
M
, Dong
X
, Qu
J
, Gong
F
, Han
Y
, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
. Lancet
. 2020 Feb 15
;395
(10223
):507
–13
. .27.
Welge-Lüssen
A
. Re-establishment of olfactory and taste functions
. GMS Curr Top Otorhinolaryngol Head Neck Surg
. 2005
;4
:Doc06
..28.
Soler
ZM
, Patel
ZM
, Turner
JH
, Holbrook
EH
. A primer on viral-associated olfactory loss in the era of COVID-19
. Int Forum Allergy Rhinol
. 2020 Apr 9
;10
:814
–20
.29.
Sungnak
W
, Huang
N
, Bécavin
C
, Berg
M
, Queen
R
, Litvinukova
M
, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
. Nat Med
. 2020 April 23
;26
:681
–7
.30.
Butowt
R
, Bilinska
K
. SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection
. ACS Chem Neurosci
. 2020 Apr 13
;11
:1200
–3
.31.
Chen
R
, Wang
K
, Yu
J
, Chen
Z
, Wen
C
, Xu
Z
. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain
. bioRxiv
. 2020
.32.
Sarma
D
, Bilello
LA
. A case report of acute transverse myelitis following novel coronavirus infection
. Clin Pract Cases Emerg Med
. 2020 Aug
;4
(3
):321
–3
. .33.
Pezzini
A
, Padovani
A
. Lifting the mask on neurological manifestations of COVID-19
. Nat Rev Neurol
. 2020 November1
;16
(11
):636
–44
. .34.
Wang
Y
, Li
X
, Wei
B
, Tung
TH
, Tao
P
, Chien
CW
. Association between chronic obstructive pulmonary disease and dementia: systematic review and meta-analysis of cohort studies
. Dement Geriatr Cogn Dis Extra
. 2019 May-Aug
;9
(2
):250
–9
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
